Research at Medisure Labs

Medisure Labs Inc is not just a testing lab, we are a working research lab. Behind every panel we run is a team asking what comes next, not just what is standard.

Research here is not a side project. It shapes the panels we build, the markers we test for, and the way we help doctors understand pathogenic infections and population-level health trends.

Our current research priorities include:

• Expanding hereditary disease panels as new gene-disease links are validated
• Improving PCR assay sensitivity against emerging and drug-resistant pathogens
• Reducing false positives in toxicology confirmatory testing
• Building reference data specific to the populations we serve

Our research is carried out by a busy team of molecular scientists and PhD researchers who work around the clock developing new assays and panels.

This work is aimed at:

• Enhancing population health through earlier, more precise detection
• Improving treatment and care outcomes for patients and providers
• Keeping our test menu aligned with current science, not last decade's

Our scientists bring backgrounds spanning molecular biology, clinical pathology, and bioinformatics, which means new findings move from the bench to the test menu faster, without sacrificing the validation work that keeps results reliable.

Good research rarely happens in isolation. Medisure Labs Inc has collaborated with research agencies in the UAE and Asia to expand what our science can do.

These partnerships give us access to broader data sets and shared expertise, and help validate our work across a wider range of populations and conditions.

These collaborations typically focus on:

• Cross-population validation of genetic and genomic testing panels
• Joint surveillance projects tracking infectious disease trends
• Shared toxicology reference ranges across different patient groups

As our research progresses, so does our testing menu.

New panels and tests are added on an ongoing basis, benefiting:

• Doctors, who gain sharper diagnostic tools for their patients
• Patients, who get access to more accurate, up-to-date testing
• Research agencies, who gain a dependable lab partner for new studies

Every new addition goes through the same validation process as our founding panels: internal quality controls, proficiency testing, and a review of clinical evidence before it ever reaches a patient sample.

Medisure Labs Inc is always open to new research collaborations, whether with academic institutions, government agencies, or industry partners.

We are especially interested in partnerships that involve:

• Hereditary and rare disease cohort studies
• Infectious disease surveillance and outbreak response research
• Toxicology reference range development for underserved populations

If your organization is exploring a research partnership in molecular diagnostics, genomics, or toxicology, we would like to hear from you. Contact Us